Market Overview:
The global electrophysiology mapping and ablation devices market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiac arrhythmias, technological advancements in electrophysiology mapping and ablation devices, and rising demand for minimally invasive procedures. Based on type, the global electrophysiology mapping and ablation devices market can be segmented into conventional devices, advanced devices, ultrasound devices, cryoablation devices, microwave ablation (MWA)devices,,and others. The advanced device segment is expected to grow at a higher CAGR than other segments during the forecast period owing to its ability to provide accurate lesion formation as well as reduced procedure time as compared with conventional techniques. Based on application, the global electrophysiology mapping and ablation Devices Market can be divided into atrial fibrillation (AF), premature ventricular contractions (PVCs), atrial flutter (AFL), AV re-entrant tachycardia(AVRT), AV nodal tachycardia(AVNT)and others.
Product Definition:
Electrophysiology Mapping And Ablation Devices are used to help diagnose and treat heart conditions. They can help identify abnormal heart rhythms, and determine the best way to treat them.
Conventional:
Conventional is the term used to define a set of procedures and techniques that are widely accepted in medical practice. The conventional methods for mapping and ablating heart valves, vascular structures, nerves, etc. have been around for quite some time now; hence they are well known by most surgeons across the world.
Advanced:
Advanced is a term used in the field of electrophysiology mapping and ablation devices. It basically means more accurate, sensitive, and reliable than conventional methods. The advanced techniques are based on Artificial Intelligence (AI), Machine Learning (ML), deep learning and other such technologies that help in improving the accuracy of medical procedures.
Application Insights:
Electrophysiology mapping and ablation devices are used for the treatment of various arrhythmia conditions including atrial fibrillation, premature ventricular contractions (PVC), atrial flutter, AV nodal re-entry tachycardia, and others. In 2017, the PVC segment dominated the market with a share of 29.0% in terms of revenue. The high prevalence of PVCs among patients suffering from hypertension is one of the major factors contributing to its dominance over other application segments during that year.
The AF segment is expected to grow significantly during the forecast period owing to increasing incidence rates as well as awareness regarding early diagnosis & treatment options for this condition worldwide. According to data published by ELSO in 2018, nearly 5 million individuals were affected by AF globally; Of these 2 million were diagnosed and 1 million suffered from it undiagnosed leading to an estimated mortality rate respectively amongst 3% and 6%.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of centers and institutes involved in conducting research related to electrophysiology mapping and ablation devices. Moreover, increasing demand for minimally invasive surgeries is also expected to drive growth during the forecast period.
Moreover, favorable government initiatives pertaining their support towards R&D activities conducted by medical device manufacturers are anticipated boost regional market development over the next eight years.
Growth Factors:
- Increasing incidence of cardiac arrhythmias: The global prevalence of cardiac arrhythmias is high and is estimated to be around 2-3% in the general population. This number is likely to increase in the future due to various factors such as increasing aging population, rising rates of obesity and diabetes, and increasing exposure to environmental stressors. This will create a large pool of patients who will require electrophysiology mapping and ablation devices for treatment.
- Technological advancements: The electrophysiology mapping and ablation devices market is witnessing rapid technological advancements, with new products being launched regularly. These advances are helping to improve the accuracy and efficacy of these devices, which is resulting in increased adoption by physicians worldwide.
- Growing demand for minimally invasive procedures: There is a growing demand for minimally invasive procedures across all medical specialties due to their many advantages over traditional surgery such as reduced pain, shorter hospital stay, faster recovery time, etc. Electrophysiology mapping and ablation devices are ideally suited for use in minimally invasive procedures owing to their small size and portability. This will help fuel their growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Electrophysiology Mapping And Ablation Devices Market Research Report
By Type
Conventional, Advanced, Ultrasound, Cryoablation, Microwave
By Application
Atrial Fibrillation, Premature Ventricular Contractions (PVC), Atrial Flutter, AV Re-entrant Tachycardia, AV Nodal Tachycardia
By Companies
Arrow International Inc., AtriCure Inc., Biosense Webster Inc., Boston Scientific Corp., C.R. Bard Inc., Endosense SA, Hansen Medical Inc., Medtronic Inc., St. Jude Medical Inc., Stereotaxis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Electrophysiology Mapping And Ablation Devices Market Report Segments:
The global Electrophysiology Mapping And Ablation Devices market is segmented on the basis of:
Types
Conventional, Advanced, Ultrasound, Cryoablation, Microwave
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Atrial Fibrillation, Premature Ventricular Contractions (PVC), Atrial Flutter, AV Re-entrant Tachycardia, AV Nodal Tachycardia
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Arrow International Inc.
- AtriCure Inc.
- Biosense Webster Inc.
- Boston Scientific Corp.
- C.R. Bard Inc.
- Endosense SA
- Hansen Medical Inc.
- Medtronic Inc.
- St. Jude Medical Inc.
- Stereotaxis
Highlights of The Electrophysiology Mapping And Ablation Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Conventional
- Advanced
- Ultrasound
- Cryoablation
- Microwave
- By Application:
- Atrial Fibrillation
- Premature Ventricular Contractions (PVC)
- Atrial Flutter
- AV Re-entrant Tachycardia
- AV Nodal Tachycardia
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Electrophysiology Mapping And Ablation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Electrophysiology mapping and ablation devices are medical instruments that use electrical current to map the function of individual cells or tissues. This information can then be used to treat diseases by destroying the cells that are causing the problem.
Some of the major companies in the electrophysiology mapping and ablation devices market are Arrow International Inc., AtriCure Inc., Biosense Webster Inc., Boston Scientific Corp., C.R. Bard Inc., Endosense SA, Hansen Medical Inc., Medtronic Inc., St. Jude Medical Inc., Stereotaxis.
The electrophysiology mapping and ablation devices market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Electrophysiology Mapping And Ablation Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Electrophysiology Mapping And Ablation Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Electrophysiology Mapping And Ablation Devices Market - Supply Chain
4.5. Global Electrophysiology Mapping And Ablation Devices Market Forecast
4.5.1. Electrophysiology Mapping And Ablation Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Electrophysiology Mapping And Ablation Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Electrophysiology Mapping And Ablation Devices Market Absolute $ Opportunity
5. Global Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Type
5.3.1. Conventional
5.3.2. Advanced
5.3.3. Ultrasound
5.3.4. Cryoablation
5.3.5. Microwave
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Application
6.3.1. Atrial Fibrillation
6.3.2. Premature Ventricular Contractions (PVC)
6.3.3. Atrial Flutter
6.3.4. AV Re-entrant Tachycardia
6.3.5. AV Nodal Tachycardia
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Electrophysiology Mapping And Ablation Devices Demand Share Forecast, 2019-2029
9. North America Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Application
9.4.1. Atrial Fibrillation
9.4.2. Premature Ventricular Contractions (PVC)
9.4.3. Atrial Flutter
9.4.4. AV Re-entrant Tachycardia
9.4.5. AV Nodal Tachycardia
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Type
9.7.1. Conventional
9.7.2. Advanced
9.7.3. Ultrasound
9.7.4. Cryoablation
9.7.5. Microwave
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Electrophysiology Mapping And Ablation Devices Demand Share Forecast, 2019-2029
10. Latin America Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Application
10.4.1. Atrial Fibrillation
10.4.2. Premature Ventricular Contractions (PVC)
10.4.3. Atrial Flutter
10.4.4. AV Re-entrant Tachycardia
10.4.5. AV Nodal Tachycardia
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Type
10.7.1. Conventional
10.7.2. Advanced
10.7.3. Ultrasound
10.7.4. Cryoablation
10.7.5. Microwave
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Electrophysiology Mapping And Ablation Devices Demand Share Forecast, 2019-2029
11. Europe Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Application
11.4.1. Atrial Fibrillation
11.4.2. Premature Ventricular Contractions (PVC)
11.4.3. Atrial Flutter
11.4.4. AV Re-entrant Tachycardia
11.4.5. AV Nodal Tachycardia
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Type
11.7.1. Conventional
11.7.2. Advanced
11.7.3. Ultrasound
11.7.4. Cryoablation
11.7.5. Microwave
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Electrophysiology Mapping And Ablation Devices Demand Share, 2019-2029
12. Asia Pacific Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Application
12.4.1. Atrial Fibrillation
12.4.2. Premature Ventricular Contractions (PVC)
12.4.3. Atrial Flutter
12.4.4. AV Re-entrant Tachycardia
12.4.5. AV Nodal Tachycardia
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Type
12.7.1. Conventional
12.7.2. Advanced
12.7.3. Ultrasound
12.7.4. Cryoablation
12.7.5. Microwave
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Electrophysiology Mapping And Ablation Devices Demand Share, 2019-2029
13. Middle East & Africa Electrophysiology Mapping And Ablation Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Application
13.4.1. Atrial Fibrillation
13.4.2. Premature Ventricular Contractions (PVC)
13.4.3. Atrial Flutter
13.4.4. AV Re-entrant Tachycardia
13.4.5. AV Nodal Tachycardia
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Electrophysiology Mapping And Ablation Devices Market Size and Volume Forecast by Type
13.7.1. Conventional
13.7.2. Advanced
13.7.3. Ultrasound
13.7.4. Cryoablation
13.7.5. Microwave
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Electrophysiology Mapping And Ablation Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Electrophysiology Mapping And Ablation Devices Market: Market Share Analysis
14.2. Electrophysiology Mapping And Ablation Devices Distributors and Customers
14.3. Electrophysiology Mapping And Ablation Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Arrow International Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AtriCure Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Biosense Webster Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boston Scientific Corp.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. C.R. Bard Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Endosense SA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hansen Medical Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medtronic Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. St. Jude Medical Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Stereotaxis
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
&nb
